| Número de catálogo | HF687096 |
| Especie huésped | Chimeric |
| Reactividad de especies | Human |
| Forma | Liquid |
| Buffer de almacenamiento | 0.01M PBS, pH 7.4. |
| Pureza | >95% purity as determined by SDS-PAGE. |
| Clonalidad | Monoclonal |
| Isotipo | VH-VH' |
| Aplicaciones | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Objetivo | CPAMD4, C5, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4, Complement C5, ALB, Albumin |
| Purificación | Protein A/G purified from cell culture supernatant. |
| Nivel de endotoxinas | Please contact the lab for this information. |
| Sistema de expresión | Mammalian Cells |
| Número de acceso | P01031 & P02768 |
| Estabilidad y almacenamiento | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternative name | Bispecific, ALXN-1720, ALXN1720, CON-9978, TPP-2511, 2456407-94-4 |
| Nota | For research use only. Not suitable for clinical or therapeutic use. |
Research Grade Gefurulimab
Vista general
Descripción
Gefurulimab (HF687096) is a research-grade recombinant antibody targeting CPAMD4. Produced in mammalian cells with native-like glycosylation.
Highlights
- ●Research Grade — For PK/PD studies, assay development, and ADA research.
- ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Imágenes
 SDS-PAGE |
SDS-PAGE for Research Grade Gefurulimab. |